Jpmorgan Chase & CO Outset Medical, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Outset Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,114,700 shares of OM stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,114,700
Previous 4,961,199
37.22%
Holding current value
$12 Million
Previous $26.8 Million
74.24%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding OM
# of Institutions
122Shares Held
41MCall Options Held
63.4KPut Options Held
32.1K-
Ameriprise Financial Inc Minneapolis, MN5.11MShares$19.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$15.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$12.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$11.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT2.4MShares$9.24 Million0.17% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $185M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...